2030 年亚太鱼疫苗市场预测 - 区域分析 - 按疫苗类型、应用、给药途径和物种
市场调查报告书
商品编码
1481942

2030 年亚太鱼疫苗市场预测 - 区域分析 - 按疫苗类型、应用、给药途径和物种

Asia Pacific Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species

出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 订单完成后即时交付

价格

2022年亚太鱼苗市场估值为4,687万美元,预计2030年将达9,415万美元;预计 2022 年至 2030 年复合年增长率为 9.1%。

新型鱼疫苗的开发推动亚太鱼疫苗市场的发展

由寄生虫、病毒和细菌引起的疾病爆发已经减缓了全球水产养殖业数十年的发展。除了危害人类健康外,新出现的疾病也对水生动物产生重大影响。传统疫苗有其限制和缺点,这增加了对嵌合多表位疫苗等新型先进疫苗开发的需求。科学技术的进步为水产疫苗的基础和应用研究领域开闢了新的途径。人们努力利用新技术、新方法、新策略来创造更高品质、更高效率的新型水生疫苗。

利用现有的生物资讯学工具以及免疫蛋白质组学和基因组学的现有知识,研究人员可以识别免疫细胞可以识别的潜在目标表位。此外,随着全基因组定序等技术的成本持续下降,它为物种特异性疫苗的开发开闢了道路。这可能会增加开发新疫苗的投资。 2021年,中央咸水水产养殖研究所(ICAR)在印度推出了针对病毒性神经坏死(VNN)的重组疫苗。

因此,开发有效的黏膜疫苗并加强管理流程预计将加速新型疫苗的开发,这将促进地中海国家的水产养殖业规范鱼类疫苗接种过程。因此,新型鱼类疫苗的开发可能为市场成长创造重大机会。

亚太鱼疫苗市场概况

亚太鱼疫苗市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。这些国家的市场成长归功于该地区水产养殖业的崛起和政府的有利措施。此外,市场参与者实施的扩张和产品推出策略预计将有助于该地区鱼疫苗市场的成长。自第二次世界大战结束以来,日本的商业水产养殖生产迅速发展,在渔业部门中占有重要地位。年度渔业统计的水产养殖部分包括60多个物种。其中,主要品种有海苔、扇贝、牡蛎、鰤、真鲷、海芥等。然而,未来十年国内对海鲜的需求将下降,水产养殖如果继续依赖国内需求,产量也会下降。日本需求下降是因为日本人口减少,他们的饮食转向肉类。

亚太鱼疫苗市场收入及 2030 年预测(百万美元)

亚太鱼疫苗市场区隔

亚太鱼苗市场根据疫苗类型、应用、给药途径、物种和国家进行细分。

依疫苗类型,亚太鱼苗市场分为灭活疫苗、减毒活疫苗、次单位疫苗、重组载体疫苗等。 2022 年,灭活疫苗细分市场占据最大市场份额。

根据应用,亚太鱼苗市场分为细菌感染、病毒感染和寄生虫。 2022 年,细菌感染细分市场占最大市场。

根据给药途径,亚太鱼苗市场分为注射疫苗、浸没疫苗和口服疫苗。 2022年,注射疫苗细分市场占据最大市场份额。

根据物种,亚太鱼苗市场分为鲑鱼、鳟鱼、罗非鱼等。 2022 年,鲑鱼细分市场占据最大的市场。

依国家划分,亚太鱼疫苗市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022 年,日本在亚太鱼疫苗市场份额中占据主导地位。

崇安疫苗实验室有限公司; Elanco 动物保健公司;希普拉公司;印度免疫学有限公司; KBNP 公司;京都美研研究所;默克公司;日精研有限公司; Phibro 动物健康公司; Vaxxinova 国际有限公司;和 Zoetis Inc. 是亚太鱼疫苗市场上的一些领先公司。

目录

第 1 章:简介

第 2 章:执行摘要

  • 亚太鱼疫苗市场

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:亚太鱼疫苗市场 - 主要产业动态

  • 市场驱动因素:
    • 政府发展水产养殖业的倡议
    • 水产动物性食品的需求激增
  • 市场限制
    • 疫苗审批的严格规定
  • 市场机会
    • 新型鱼类疫苗的研发
  • 未来的趋势
    • 鱼类疫苗的技术进步
  • 影响分析:

第 5 章:鱼疫苗市场 - 亚太市场分析

  • 鱼疫苗市场收入(千美元),2022 - 2030

第 6 章:亚太鱼疫苗市场 - 收入和 2030 年预测 - 按疫苗类型

  • 概述
  • 2022 年及 2030 年鱼疫苗市场收入份额(以疫苗类型)(%)
  • 灭活疫苗
  • 减毒活疫苗
  • 亚单位疫苗
  • 重组载体疫苗
  • 其他的

第 7 章:亚太鱼疫苗市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年及 2030 年鱼疫苗市场收入份额(按应用划分)(%)
  • 细菌感染
  • 病毒感染
  • 寄生

第 8 章:亚太鱼疫苗市场 - 收入和 2030 年预测 - 按给药途径

  • 概述
  • 2022 年及 2030 年鱼疫苗市场收入份额(按给药途径)(%)
  • 注射疫苗
  • 浸没疫苗
  • 口服疫苗

第 9 章:亚太鱼疫苗市场 - 收入和 2030 年预测 - 按物种

  • 概述
  • 2022 年和 2030 年按物种分類的鱼疫苗市场收入份额 (%)
  • 鲑鱼
  • 鳟鱼
  • 罗非鱼
  • 其他的

第 10 章:亚太鱼疫苗市场 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区

第 11 章:鱼疫苗市场 - 产业格局

  • 概述
  • 鱼疫苗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章:公司简介

  • Zoetis Inc
  • Merck & Co Inc
  • HIPRA SA
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Nisseiken Co Ltd
  • KBNP Inc
  • Choong Ang Vaccine Laboratory
  • Indian Immunologicals Ltd

第 13 章:附录

Product Code: BMIRE00029704

The Asia Pacific fish vaccines market was valued at US$ 46.87 million in 2022 and is expected to reach US$ 94.15 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Development of Novel Fish Vaccine Fuels the Asia Pacific Fish Vaccine Market

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.

Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.

Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.

Asia Pacific Fish Vaccines Market Overview

The Asia Pacific fish vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the fish vaccines market in the region. Commercial aquaculture production in Japan has developed dramatically since the end of the 2nd World War and occupies an important place in the fisheries sector. More than 60 species are included in the aquaculture section of the annual fisheries statistics. Of these, the main species are Nori, yesso scallop, oyster, Japanese amberjack, red seabream, and sea mustard. However, domestic demand for seafood products will decline in the next decade, and the production of aquaculture will decline if it remains dependent on domestic demand. This decline in demand in Japan is because Japan's population is dropping, and their diets are shifting toward meat.

Asia Pacific Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fish Vaccines Market Segmentation

The Asia Pacific fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Asia Pacific fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Asia Pacific fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Asia Pacific fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Asia Pacific fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Asia Pacific fish vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific fish vaccines market share in 2022.

Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc. are some of the leading companies operating in the Asia Pacific fish vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Fish Vaccine Market

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Fish Vaccine Market - Key Industry Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Government Initiatives to Develop Aquaculture Industry
    • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 4.2 Market Restraints
    • 4.2.1 Stringent Regulations for Approval of Vaccine
  • 4.3 Market Opportunities
    • 4.3.1 Development of Novel Fish Vaccine
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Fish Vaccine
  • 4.5 Impact Analysis:

5. Fish Vaccine Market - Asia Pacific Market Analysis

  • 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

  • 6.1 Overview
  • 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • 6.3 Inactivated Vaccines
    • 6.3.1 Overview
    • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Live Attenuated Vaccines
    • 6.4.1 Overview
    • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Subunit Vaccines
    • 6.5.1 Overview
    • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Recombinant Vector Vaccine
    • 6.6.1 Overview
    • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • 7.3 Bacterial Infection
    • 7.3.1 Overview
    • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Viral Infection
    • 7.4.1 Overview
    • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Parasitic
    • 7.5.1 Overview
    • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • 8.3 Injection vaccine
    • 8.3.1 Overview
    • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Immersion Vaccine
    • 8.4.1 Overview
    • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Oral Vaccine
    • 8.5.1 Overview
    • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

  • 9.1 Overview
  • 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
  • 9.3 Salmon
    • 9.3.1 Overview
    • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Trout
    • 9.4.1 Overview
    • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Tilapia
    • 9.5.1 Overview
    • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Asia Pacific Fish Vaccine Market - Country Analysis

  • 10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Fish Vaccine Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Fish Vaccine Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zoetis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 HIPRA SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Phibro Animal Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Vaxxinova International BV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Kyoto Biken Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Elanco Animal Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nisseiken Co Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 KBNP Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Choong Ang Vaccine Laboratory
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Indian Immunologicals Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Fish Vaccine Market Segmentation
  • Table 2. Worldwide Fish Production and Consumption in 2022
  • Table 3. Major Bacterial Diseases in Fish
  • Table 4. Major Viral Diseases in Fish
  • Table 5. Major Parasitic Diseases in Fish
  • Table 6. Atlantic Salmon Production 2020
  • Table 7. China Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. China Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 9. China Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 10. China Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 11. Japan Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 12. Japan Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 13. Japan Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 14. Japan Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 15. India Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 16. India Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 17. India Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 18. India Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 19. Australia Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 20. Australia Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 21. Australia Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 22. Australia Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 23. South Korea Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 24. South Korea Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 25. South Korea Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 26. South Korea Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 27. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 28. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 29. Rest of Asia Pacific Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 30. Rest of Asia Pacific Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
  • Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
  • Table 33. Glossary of Terms, Asia Pacific Fish Vaccine Market

List Of Figures

  • Figure 1. Asia Pacific Fish Vaccine Market Segmentation, By Country
  • Figure 2. Asia Pacific Fish Vaccine Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
  • Figure 5. Asia Pacific Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 11. Asia Pacific Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. Asia Pacific Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
  • Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 24. Asia Pacific Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
  • Figure 25. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
  • Figure 26. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 27. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 28. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 29. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 30. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 31. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 32. Growth Strategies in Fish Vaccine Market